Stock listing
Sichuan Biokin Pharmaceutical Co., Ltd. Class A
Selected listing: 688506 · SSE · CNY · CN
Sichuan Biokin Pharmaceutical Co., Ltd. Class A (Shanghai:688506), Health Technology. Latest release Sep 30, 2026: (688506)"SICHUAN BIOKIN PHARMACEUTICAL CO.…
- Ticker
- Shanghai:688506
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About Sichuan Biokin Pharmaceutical Co., Ltd. Class A
Sichuan Biokin Pharmaceutical Co., Ltd. Class A is a publicly traded company in China, identified by the ticker 688506. Biokin specializes in the development and production of pharmaceutical products, contributing to the healthcare sector in China.
Latest news from Sichuan Biokin Pharmaceutical Co., Ltd. Class A
(688506)"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Temporary Use of Certain Idle Raised Funds to Supplement Working Capital
September 29, 2026
(688506)"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Appointment of Securities Affairs Representative
September 29, 2026
"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of the Completion of Enrollment of the First Subject in the Phase III Clinical Trial of T-Bren for Injection (HER2 ADC) for the Treatment of HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
September 29, 2026
(688506)"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of the Inclusion of T-Bren (HER2 ADC) in the List of Breakthrough Therapy Designations for Patients with HER2-Expressing Locally Advanced or Metastatic Biliary Tract Cancer Who Have Failed Platinum-based Chemotherapy
September 27, 2026
(688506)"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of the Inclusion of iza-bren (izalontamab brengitecan, BL-B01D1) in the List of Breakthrough Therapy Designations for Patients with Recurrent or Metastatic Biliary Tract Cancer Who Have Failed Prior Platinum-based Chemotherapy
September 27, 2026
Research Sichuan Biokin Pharmaceutical Co., Ltd. Class A
Sichuan Biokin Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Sichuan Biokin Pharmaceutical Co., Ltd. Class A on 6ix.
Sichuan Biokin Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Sichuan Biokin Pharmaceutical Co., Ltd. Class A.
Sichuan Biokin Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Sichuan Biokin Pharmaceutical Co., Ltd. Class A.